Pharmacokinetic study of oral and bolus intravenous 2-chlorodeoxyadenosine in patients with malignancy.

No abstract is available for this paper.

• Publication year

  1996

• Venue

  Journal of Clinical Oncology

• Publication date

  1996-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1200/JCO.1996.14.3.978PMID 8622049
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• 2-Chlorodeoxyadenosine activity in patients with untreated chronic lymphocytic leukemia.

  1995cited by this paper
• Cladribine in the treatment of relapsed or refractory chronic lymphocytic leukemia.

  1995cited by this paper
• 2-Chlorodeoxyadenosine: A Newer Purine Analog Active in the Treatment of Indolent Lymphoid Malignancies

  1994cited by this paper
• 2-Chlorodeoxyadenosine is an active salvage therapy in advanced indolent non-Hodgkin's lymphoma.

  1994cited by this paper
• Newer purine analogues for the treatment of hairy-cell leukemia.

  1994cited by this paper
• Relationship of deoxycytidine kinase and cytoplasmic 5'-nucleotidase to the chemotherapeutic efficacy of 2-chlorodeoxyadenosine.

  1993cited by this paper
• High complete remission rate from 2-chloro-2'-deoxyadenosine in previously treated patients with B-cell chronic lymphocytic leukemia: response predicted by rapid decrease of blood lymphocyte count.

  1993cited by this paper
• Treatment of Waldenstrom Macroglobulinemia with 2-Chlorodeoxyadenosine

  1993cited by this paper
• 2-Chlorodeoxyadenosine: an active agent in the treatment of cutaneous T-cell lymphoma.

  1992cited by this paper
• Treatment of hairy cell leukemia with 2-chlorodeoxyadenosine (2-CdA).

  1992cited by this paper
• A single cycle of 2-chlorodeoxyadenosine results in complete remission in the majority of patients with hairy cell leukemia.

  1992cited by this paper
• 2-Chlorodeoxyadenosine treatment of low-grade lymphomas.

  1992cited by this paper
• On the bioavailability of oral and subcutaneous 2-chloro-2'-deoxyadenosine in humans: alternative routes of administration.

  1992cited by this paper
• 2-Chlorodeoxyadenosine Treatment of Refractory Chronic Lymphocytic Leukemia.

  1991cited by this paper
• Lasting remissions in hairy-cell leukemia induced by a single infusion of 2-chlorodeoxyadenosine.

  1990cited by this paper
• Inhibition of DNA repair by deoxyadenosine in resting human lymphocytes.

  1986cited by this paper
• Mechanism of deoxyadenosine and 2-chlorodeoxyadenosine toxicity to nondividing human lymphocytes.

  1985cited by this paper
• Antileukemic and immunosuppressive activity of 2-chloro-2'-deoxyadenosine.

  1984cited by this paper
• Toxicity and response criteria of the Eastern Cooperative Oncology Group

  1982cited by this paper
• Posterior probabilities for choosing a regression model

  1978cited by this paper
• Estimating the Dimension of a Model

  1978cited by this paper

• Effect of cladribine tablets on lymphocyte reduction and repopulation dynamics in patients with relapsing multiple sclerosis.

  2019cites this paper
• Cladribine in the remission induction of adult acute myeloid leukemia: where do we stand?

  2018cites this paper
• The Clinical Pharmacology of Cladribine Tablets for the Treatment of Relapsing Multiple Sclerosis

  2018cites this paper
• Population Pharmacokinetics of Cladribine in Patients with Multiple Sclerosis

  2017cites this paper
• Oral Chemotherapy Agents in the Treatment of Leukaemia

  2012cites this paper
• Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias.

  2012cites this paper
• [Treatment for recurrent hairy cell leukemia].

  2012cites this paper
• Rare B Cell Lymphoproliferative Disorders

  2012cites this paper
• Phase I/II and pharmacokinetic study of cladribine with 2‐h infusion in Japanese patients with relapsed indolent B‐cell lymphoma mostly pretreated with rituximab

  2009cites this paper
• Current Status of Older and New Purine Nucleoside Analogues in the Treatment of Lymphoproliferative Diseases

  2009cites this paper
• Purine analogues: rationale for development, mechanisms of action, and pharmacokinetics in hairy cell leukemia.

  2006cites this paper
• Cladribine: An Investigational Immunomodulatory Agent for Multiple Sclerosis

  2006cites this paper
• Cladribine in hairy cell leukemia.

  2006cites this paper
• Purine nucleoside analogs as immunosuppressive and antineoplastic agents: mechanism of action and clinical activity.

  2006cites this paper
• Older and new formulations of cladribine. Pharmacology and clinical efficacy in hematological malignancies.

  2006cites this paper
• Therapy of Chronic Lymphocytic Leukaemia with Purine Nucleoside Analogues

  2005cites this paper
• Application of population pharmacokinetics to cladribine

  2005influential citation
• Influence of 2-chlorodeoxyadenosine (cladribine) on human erythrocytes.

  2004cites this paper
• Metabolism of the antineoplastic and immunosuppressive drug 2-CdA (Leustatin®) in animals and humans

  2004cites this paper
• The influence of 2‐chlorodeoxyadenosine (2‐CdA) on the adenine energy charge and glutathione content of human erythrocytes

  2004cites this paper
• Cytotoxicity and pharmacokinetics of cladribine metabolite, 2-chloroadenine in patients with leukemia.

  2004cites this paper
• Handbook of Anticancer Pharmacokinetics and Pharmacodynamics

  2004cites this paper
• Cladribine: from the bench to the bedside – focus on hairy cell leukemia

  2004cites this paper
• Pharmacological Basis for Cladribine Resistance

  2003cites this paper
• Cladribine in the treatment of hairy-cell leukaemia.

  2003cites this paper
• Treatment of hairy cell leukemia with cladribine (2-chlorodeoxyadenosine) by subcutaneous bolus injection: a phase II study.

  2002cites this paper
• Hairy Cell Leukemia

  2002cites this paper
• Nucleoside analogues in the treatment of haematological malignancies

  2001cites this paper
• Pharmacokinetics of 2-chloro-2′-deoxyadenosine administered subcutaneously or by continuous intravenous infusion

  2000cites this paper
• Clinical Pharmacokinetics of Nucleoside Analogues

  2000cites this paper
• Clinical Pharmacokinetics of 2′-Deoxy-2′-Methylidenecytidine (DMDC), a Deoxycytidine Analogue Antineoplastic Agent

  2000cites this paper
• Effect of a 2‐hour infusion of 2‐chlorodeoxyadenosine in the treatment of refractory or previously untreated Waldenström's macroglobulinemia

  1999cites this paper
• 2‐Chlorodeoxyadenosine (cladribine) in the treatment of hairy cell leukemia and hairy cell leukemia variant: 7‐year experience in Poland

  1999cites this paper
• Current Clinical Practice: Treatment of Hairy Cell Leukemia at the Close of the 20th Century

  1999cites this paper
• Cladribine activity in adult langerhans-cell histiocytosis.

  1999cites this paper
• Treatment of hairy-cell leukemia: current views.

  1999cites this paper
• CLINICAL OBSERVATIONS, INTERVENTIONS, AND THERAPEUTIC TRIALS Cladribine Activity in Adult Langerhans-Cell Histiocytosis

  1999cites this paper
• Pharmacokinetics of cladribine in plasma and its 5'-monophosphate and 5'-triphosphate in leukemic cells of patients with chronic lymphocytic leukemia.

  1998cites this paper
• Determination of 2-chlorodeoxyadenosine (cladribine, 2-CdA) in human plasma by liquid chromatography-atmospheric pressure chemical ionization mass spectrometry.

  1998cites this paper
• Bolus administration of cladribine in the treatment of Waldenström macroglobulinaemia

  1998cites this paper
• New drugs in non-Hodgkin's lymphoma.

  1997cites this paper
• The Clinical Pharmacokinetics of Cladribine

  1997cites this paper
• Transient Expression of a Purine-Selective Nucleoside Transporter (SPNTint) in a Human Cell Line (HeLa)

  1997cites this paper
• 2-chlorodeoxyadenosine administration to patients with the myeloid blast phase of chronic myelogenous leukemia.

  1997cites this paper
• Review : Purine nucleoside analogs: fludarabine, entostatin and cladribine

  1997cites this paper
• Stability and analysis of 2-chloro-2'-deoxyadenosine, 2-chloro-2'-arabino-fluoro-2'-deoxyadenosine and 2-chloroadenine in human blood plasma.

  1997cites this paper
• 2-Chlorodeoxyadenosine: a potent antimetabolite with major activity in the treatment of indolent lymphoproliferative disorders.

  1996cites this paper
• Pharmacology of purine nucleoside analogues.

  1996cites this paper
• Perspectives on purine analogues.

  1996cites this paper
• 2-chloro-2'-deoxyadenosine: clinical applications in hematology.

  1996cites this paper